Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, was quoted by FierceHealthIT in “Health IT Oversight Requires Legislative Action, Groups Argue.”
Following is an excerpt:
Brad Thompson, a health attorney with Epstein Becker Green, said while fundamentally he agrees that legislation may be needed, policymakers have not found common ground as far as the direction of such efforts.
"Rushing to do something is a recipe for bad policy," Thompson told FierceHealthIT in an email. "It can cause more harm than good and bring more confusion than clarity."
To that end, Thompson said, he and his colleagues want to see "granular-level" guidance from the U.S. Food and Drug Administration on regulation.
"We are hopeful that yet this fall FDA will publish guidance documents on the difference between wellness and disease, the scope of medical device accessories and the portion of clinical decision support software the agency regulates," he told FierceHealthIT. "We believe meaningful clarity in that area will help unleash the potential that is found in health IT."
